Skip to main content
. 2017 Jun 1;117(1):89–101. doi: 10.1038/bjc.2017.156

Table 2. Expression of miR-7, miR-221-5p and miR-339-5p in Human Breast Cancer.

  miR-7
miR-221-5p
miR-339-5p
Patients N Mean s.d. s.e. P-value N Mean s.d. s.e. P-value N Mean s.d. s.e. P-value
Normal 15 87.90 141.10 36.40   20 73.30 114.10 25.50   22 73.80 105.20 22.40  
Tumour 66 57.89 67.39 8.29   80 56.73 62.08 6.94   80 43.45 49.18 5.50  
NPI1 34 69.60 82.70 14.20   38 66.00 78.40 12.70   39 51.20 62.80 10.10  
NPI2 18 54.10 56.60 13.30   26 51.57 48.08 9.43   25 38.89 35.57 7.11  
NPI3 12 35.68 15.10 4.36 0.028 vs NPI1 14 45.50 29.93 8.00   13 33.79 21.06 5.84  
Grade1 11 74.10 93.40 28.10   12 71.50 93.30 26.90   12 56.20 75.40 21.80  
Grade2 14 91.30 94.20 25.20 0.0106 vs Grade3 21 83.40 77.00 16.80 0.028 vs Grade3 22 63.00 61.00 13.00 0.026 vs Grade3
Grade3 40 41.66 40.36 6.38 0.0382 vs Grade1 46 40.59 36.64 5.40   44 30.63 27.53 4.15  
TNM1 30 76.40 86.80 15.90   39 72.90 77.90 12.50   39 57.36 62.33 9.98  
TNM2 26 47.23 47.06 9.23   28 45.46 43.85 8.29 0.086 vs TNM3 28 33.20 32.04 6.05 0.043 vs TNM1
TNM3 6 29.96 4.44 1.81   7 30.54 3.30 1.25 0.0017 vs TNM1 6 22.38 2.03 0.83 0.0012 vs TNM1
TNM4 2 29.43 1.21 0.86   2 29.42 1.42 1.01   3 23.65 3.75 2.16 0.0021 vs TNM1
Alive&Well 48 64.10 77.30 11.20   58 59.75 70.18 9.21   59 45.97 55.57 7.23  
With distant metastasis 4 44.03 16.68 8.34   5 39.33 12.25 5.48   5 29.59 10.52 4.71  
With local recurrence 3 46.00 20.50 11.90   3 47.70 20.80 12.00   3 35.82 15.99 9.23  
Died of breast cancer 8 32.63 12.75 4.51   11 50.30 38.80 11.70   10 37.71 27.90 8.82  
With incidence (incl. local recurrence) 15 38.35 15.55 4.01 0.034 vs Alive and Well 19 46.99 30.68 7.04   18 35.14 21.94 5.17  
With metastasis and death 12 36.43 14.52 4.19 0.024 vs Alive and well 16 46.85 32.74 8.19   15 35 23.4 6.04  

Abbreviations: NPI=Nottingham Prognostic Index (1: <3.4 (good prognosis); 2: 3.4–5.4 (moderate prognosis); 3: >5.4 (poor prognosis)); TNM=tnm classification of malignant tumours.